Aliverti M
Riv Neurol. 1982 May-Jun;52(3):169-78.
The author reports results achieved by a benzamide, tiapride, in the treatment of 43 subjects showing post-traumatic headaches in a INAIL out patient department of neurology. The drug was administered per os at a dose of one tablet twice a day at the beginning of the treatment. In 9 cases, the posology was afterwards increased to 3 tablets. Results were good in 72,1% of the cases and the positive action of the drug was not limited to the disappearance of the headache, but was extended to the total symptomatology of the subjective syndrome of the patients suffering from cranium trauma. The drug was well tolerated in all the cases except in one: the treatment had to be interrupted on account of vertigo sensations. The author confirms the possible activity of the molecule in posttraumatic headaches. He also points out the facility that it offers for the social and working recovery of the subject.
作者报告了一种苯甲酰胺——硫必利，在国家工伤事故保险协会（INAIL）神经病学门诊部对43名创伤后头痛患者的治疗效果。治疗开始时，该药物经口服给药，剂量为每日两片，每次一片。9例患者随后剂量增加至每日三片。72.1%的病例效果良好，药物的积极作用不仅限于头痛消失，还扩展至颅脑创伤患者主观综合征的全部症状。除1例患者外，所有病例对该药物耐受性良好：该例因眩晕感而不得不中断治疗。作者证实了该分子在创伤后头痛方面可能具有的活性。他还指出了该药物对患者社交和工作恢复所提供的便利。
